- Seed Round,
- Early stage VC,
- Later stage VC
Alopexx is a clinical-stage biotechnology company developing novel monoclonal antibodies and vaccines targeting microbial antigens to prevent and treat bacterial, fungal, and parasitic infections, aiming to address antimicrobial resistance.
- CompanyAmountRound
- Example example company Inc1000000Investor meetings
- Company & Company11000000Series C funding
- Example524000Seed round A
Email visible after logging in
Example Exampleexample
Biotechnology